Review Article

Epigenetics of Meningiomas

Table 2

Epigenetic changes and their supposed role in meningiomas.

Epigenetic alterationsAffected genesDistribution between WHO gradesPossible effects in meningioma

Promoter methylationTIMP3 Grades 1 < 2 < 3Associated with tumour progression and aggressiveness parameters
HOXA7, HOXA9, and HOXA10 Grades 1 < 2 < 3Associated with tumour progression and aggressiveness parameters
RASSF1A Grades 1 < 2 < 3Associated with the malignant transformation of a meningioma
TP73 Grades 1 < 2 < 3Associated with the malignant transformation of a meningioma
NDRG2 Grades 1 < 2 < 3Associated with malignant progression and predisposition to recurrence
MAL2 Grade 1Unknown
IGF2BP1 Grade 2Increases the malignant potential of tumours
PDCD1 Grade 2Increases the malignant potential of tumours

Disturbed chromatin regulationKDM5C Grades 1 and 3Disturbed chromatin regulation
KDM6A Grade 2Disturbed chromatin regulation
SMARCB1 Grade 1 Abnormal chromatin remodelling

Abnormal microRNAs expressionmiR-29c-3p Grades 1 > 2 > 3Associated with advanced clinical stages
miR-219-5pGrades 1 > 2 > 3Associated with advanced clinical stages
miR-190aGrades 1 < 2 < 3Associated with advanced clinical stages
miR-200aUnknownFunctions as a multifunctional tumour suppressor miRNA
miR-145Grades 1 > 2; 3Has an important antimigratory and antiproliferative function